Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. - Wikidata - awgldk - TriplyDB

Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.

Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.

http://www.wikidata.org/entity/Q34006329

about

AID and APOBECs span the gap between innate and adaptive immunity Nonhuman primate models for HIV/AIDS vaccine development The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise Profiling immunity to HIV vaccines with systems biology Challenges in mucosal HIV vaccine development: lessons from non-human primate models The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice Exposure to apoptotic activated CD4+ T cells induces maturation and APOBEC3G-mediated inhibition of HIV-1 infection in dendritic cells Resistance to simian immunodeficiency virus low dose rectal challenge is associated with higher constitutive TRIM5α expression in PBMC Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response Vaccine-induced myeloid cell population dampens protective immunity to SIV The CD8 T-cell road to immunotherapy of toxoplasmosis.Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.Strategies to use immune modulators in therapeutic vaccines against cancer Systems vaccinology.Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis Modulation of SIV and HIV DNA vaccine immunity by Fas-FasL signaling Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.Mucosal and peripheral Lin- HLA-DR+ CD11c/123- CD13+ CD14- mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection.TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques.Innate immunity in acute HIV-1 infection A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum.Molecular determinants of plaque size as an indicator of dengue virus attenuation Simian immunodeficiency virus interactions with macaque dendritic cells.Relative resistance of HIV-1 founder viruses to control by interferon-alpha.Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking.Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.Humoral immunity in the Friend retrovirus infection model.Myeloid dendritic cells in HIV-1 infection.Novel approaches in polyepitope T-cell vaccine development against HIV-1.Complex correlates of protection after vaccination.Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.

P2860

Q21131084-8A4CFEA0-3EA2-4219-BF45-C937FBE0A8C4 Q26861148-16747D71-772D-4957-8254-41BC3F1ECE25 Q27010375-9A61B35C-9F09-48C6-A398-8D7AF40998D7 Q27010629-FF079269-2B68-400C-A87A-1B3CD7916C9C Q27022152-F302C3B4-AD1B-499E-ABC3-98893660E9B7 Q27305204-82504949-BAB2-4D75-95C3-84B23FB7729B Q27311568-9C176583-B736-4C01-859E-3D1B837F5289 Q28743559-56EF1ADB-DE64-440D-BC7E-C08A49ED56E7 Q30579576-0DDEE138-9F72-45B0-831D-4E3AC81E12B8 Q31036522-5850BD35-D6CB-4861-98A3-FD3E3BA580B4 Q33685961-AA298565-E439-4032-A147-9E11E77FB2E2 Q33732215-233C4C6D-58C3-4A88-9D7F-91E04EBF4196 Q33739465-46EB8BBE-0F37-4258-84F7-9D953B74F58A Q33763297-FF898721-1FF0-4EFB-917D-5A9191487230 Q33915690-D2B97297-A9DC-46EB-B307-E299049EF3AD Q34275601-D6CFC48B-2F4C-4B39-A04E-6833E17FD039 Q34402910-1020DD3B-204C-4932-9BFD-97BF014C6BE0 Q34428561-815E49FA-DA1D-4051-AEFD-68D3B0FE8E9D Q34524955-92245B0A-DE09-4915-998C-790A973AB069 Q34616275-722C868A-19FB-4B49-836F-CB0EE4162C75 Q35044067-107E385C-346B-43D2-AF45-8D7F4BC8A13B Q35076553-7EAD1C19-5CD6-435E-8259-E2B39316E4F6 Q35139265-9FCE59DE-C159-432B-80CE-53428D14B257 Q35232840-FB5B2A2E-685F-498D-90BF-050915F81CAF Q35339284-E22846C6-6A91-4256-A638-F30193260065 Q35665916-F464D77C-9895-454A-9429-99E70CB0D3B2 Q35672335-ECF487C2-A92C-4645-B2FA-0C1F4AB7F702 Q35696991-BC7F06ED-6DED-4F14-8E3C-FB17F06A9F22 Q35871793-595C28DA-AD85-4D32-ABA7-4D2C9492FD8A Q36620090-8BE155D6-1755-4FDF-A4DC-184F9D15D55D Q36906525-1EA01C5F-2B4B-4CCC-A830-CCCA74239B56 Q37177696-8ECE5101-ED44-4F82-9F01-98274DE5ED4C Q37532983-040CA348-6273-4AA9-9337-871E04D8FBC7 Q37594498-A8E2830F-718D-40D8-A9F7-2491C51BC2E4 Q37685855-DBBEF223-2FAF-4DAB-9981-FFD55B1461A2 Q37730925-3799D00B-C23F-43A0-92C9-26202638DC09 Q37899725-0ABAD96D-8078-48C3-8391-FA83747FC715 Q38168900-F2EE8D59-5096-4875-BDF4-4BCEE9CF816A Q38456515-28ED8F15-0FF1-4111-AD53-E368FF836720 Q40305499-875E5EEC-E68A-4CB4-AF1B-DABCDFE76711

P2860

Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.

http://www.wikidata.org/entity/Q34006329

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@ast

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@en

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@nl

type

label

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@ast

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@en

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@nl

prefLabel

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@ast

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@en

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@nl

P1433

Q34006329-BBF76890-78CD-4B33-A94E-0127EC86B208

P1476

Q34006329-EE29BD10-D1D7-4B94-AFA4-FEA3314E8F39

P2093

Q34006329-0044F4C9-E9D7-4EDC-B138-61274681476C

Q34006329-026DEC10-6A54-49CA-8EE8-4CC74EFA935E

Q34006329-07EA6750-DBF1-43CE-8983-95AF9A7251FC

Q34006329-1D7DE86D-A8B6-4857-95BD-841ADD66B217

Q34006329-1FBA9093-8F1F-4702-B8EE-75DDC2725B4A

Q34006329-4211F6BD-D668-42BD-BC24-53BEE77E3101

Q34006329-5694CB79-81D1-4A47-9F74-C8612B9126AD

Q34006329-5B5A5D70-18C7-4E94-827C-4E0569F2813A

Q34006329-7271FB38-BFE1-4C80-B2FB-60CE93F13B48

Q34006329-88025C73-4565-4528-8A96-4BC40A64EFDF

P2860

Q34006329-017BA7E7-4ED1-4B45-B5AB-B29E112B7700

Q34006329-055FD28C-B892-4CF9-BEE8-AFD5158016FE

Q34006329-0B0CFB4E-5301-446D-8680-07605F880B65

Q34006329-11A456A8-BC7F-442A-B4BA-AE80EDA89786

Q34006329-1587BE04-8C64-440B-AF77-7DC135341223

Q34006329-1E325700-B473-4F8C-8AC0-AA74873C60E9

Q34006329-1ED4AB45-CFDD-40C3-8BAC-ACBE22D8077C

Q34006329-2B664F1E-7D35-4DEF-8464-E91F06737D84

Q34006329-4477DE49-069B-48AD-ADDA-BCF2CC68C27E

Q34006329-4E729FE9-8D92-4103-BEAB-5528DBE03C79

P304

Q34006329-554337F7-8907-47EF-94F5-287B26FC7D0A

P31

Q34006329-CD1BF304-8507-417A-A46D-A0E85EC37AEA

P356

Q34006329-A87A6E79-A839-42DD-83ED-CEA7FF4FBBE8

P407

Q34006329-F2F44D57-44F6-4404-B6ED-B0E7C7076BC2

P433

Q34006329-08F74E07-D18F-48BC-AB48-5FD9A9C6AE5F

P478

Q34006329-AC08F044-E392-4B8E-A5AA-3DA6E4ADA0A8

P577

Q34006329-3C64C610-FABE-4D42-99DA-F1E976871B9D

P5875

Q34006329-BF76E0A9-EF3B-41EF-A7F2-61CE4526B5A3

P698

Q34006329-3E2D2C8C-7565-4AA6-8D43-81E01BE50980

P932

Q34006329-FB2295BC-BBF2-43AB-AEA6-B992AB1E5C30

P356

PNAS.0911932107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Innate and adaptive immune cor ...... ansmission of SIV in macaques.

@en

P2093

Amiran Dzutsev

http://www.w3.org/2001/XMLSchema#string

Brian Kelsall

http://www.w3.org/2001/XMLSchema#string

David Venzon

http://www.w3.org/2001/XMLSchema#string

Dennis Klinman

http://www.w3.org/2001/XMLSchema#string

Genoveffa Franchini

http://www.w3.org/2001/XMLSchema#string

Igor M Belyakov

http://www.w3.org/2001/XMLSchema#string

Jay A Berzofsky

http://www.w3.org/2001/XMLSchema#string

Masaki Terabe

http://www.w3.org/2001/XMLSchema#string

Monica Vaccari

http://www.w3.org/2001/XMLSchema#string

Qing Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

DNA deamination mediates innate immunity to retroviral infection

Toll-like receptor control of the adaptive immune responses

Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.

Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques

The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication.

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection

P304

9843-9848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0911932107

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44587763

http://www.w3.org/2001/XMLSchema#string

P698

20457926

http://www.w3.org/2001/XMLSchema#string

P932

2906837

http://www.w3.org/2001/XMLSchema#string